Industries > Pharma > Generic Drugs: World Market 2014-2024

Generic Drugs: World Market 2014-2024

& Future Prospects for Leading Companies

PUBLISHED: 20 February 2014
PAGES: 238
PRODUCT CODE:
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

Generic drugs – new study showing you trends, R&D progress, and predicted revenues

Where's the generic drugs market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 238 page report provides 154 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. As pharma patents expire, much opportunity remains.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of three exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
– Professor Joshua P. Cohen, PhD, Research Assistant Professor, Tufts Center for the Study of Drug Development, Boston, Massachusetts, USA
– David Gaugh, R.Ph., Senior Vice President of Science and Regulatory Affairs, Generic Pharmaceutical Association, Washington DC, USA
– Pieter Dylst, PhD, Post-doctoral Researcher, Katholieke Universiteit Leuven

What are the prospects in the leading regions and countries?

In addition to analyses of the overall world market, you will discover individual revenue forecasts for 14 leading national markets to 2024:
•    US
•    China
•    Japan
•    Germany
•    India
•    France
•    UK
•    Russia
•    Italy
•    Brazil
•    Mexico
•    South Korea
•    Turkey
•    Spain
•    Row

There will be growth in established pharma markets and in developing countries. Our analyses show that Japan, India, Mexico and Brazil, in particular, will continue to achieve high revenue growth to 2024. Events and progress worldwide will influence the market

Leading companies and potential for market growth

Overall world revenue for generic medicines will reach $199.2bn in 2014, our report reveals We predict strong revenue growth from 2014 to 2024. Rising demand for prescription drugs, expanding healthcare coverage, payers favouring generics and changes to prescribing will increase sales to 2024.

Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:
•    Novartis
•    Teva
•    Actavis
•    Mylan
•    Abbott
•    Pfizer
•    Fresenius Kabi
•    Hospira
•    Aspen
•    Sanofi

A company profile gives you the following information:
•    Revenue forecast for generic drugs from 2014 to 2024
•    Discussion of a company's activities and outlook
•    Recent financial results
•    Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the generics industry?

Our new report discusses issues and events affecting the generic drugs market. You will find discussions, including qualitative analyses:
•    Improving regulatory processes
•    Increasing demand for generic medicines due to demographic trends
•    High predicted growth in emerging markets
•    Price controls by governments
•    Decline in pipeline of drugs nearing patent expiry
•    Consolidation among pharmacies and healthcare payers
•    Increasing perception of generic drugs as unsafe and low quality

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Generic Drugs: World Market 2014-2024 & Future Prospects for Leading Companies report helps you

In summary, our 238 page report gives you the following knowledge:
•    Revenues forecast to 2024 for the overall world market – discover the industry's prospects, finding promising places for investments and revenues
•    Revenue forecasts to 2024 for the leading 14 national markets – US, China, Japan, India, Germany, France, UK, Russia, Brazil, Mexico, Italy, South Korea, Turkey, Spain and RoW
•    Assessment of 10 leading companies – hear about products, results and strategies inc. revenue forecasts for generic drugs to 2024
•    IP policy and other regulations – see what affects market access and entry
•    Patent expiry – find prominent drug brands facing generic competition
•    Trends of prescribers and healthcare payers – assess developments
•    Discussion of what stimulates and restrains companies and the market
•    Prospects for established companies and those seeking to enter the market
•    View opinions from our survey, seeing exclusive interviews with authorities

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the generic drugs market and leading companies. You find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs: World Market 2014-2024


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs: World Market 2014-2024


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories